New Delhi: India has a high burden of Tuberculosis, recording close to 2.64 million cases and 75,000 plus deaths in…
Read More »COVID-19
New Delhi, Jan 29: With the increasing number of COVID 19 cases across various waves around the globe, countries have…
Read More »
India’s wounds from the deadly second wave have not healed yet, and we are facing the third wave of the…
Read More »
New Delhi, Jan 05: New drugs could soon be in the offing for Zika virus (ZIKV) infection with a team…
Read More »
New Delhi, Sep 24: Researchers from the Council of Scientific and Industrial Research (CSIR)’s Pune-based National Chemical Laboratory (CSIR-NCL), Reliance…
Read More »
New Delhi, Sep 24: After helping several Indian companies in the development of vaccines for COVID-19 including clinical trials, the…
Read More »
New Delhi: In a development that could help strengthen the fight against COVID-19, the Council of Scientific and Industrial Research…
Read More »
New Delhi: The Drugs Controller General of India (DCGI) has approved Hyderabad-based Biological E. Limited for conducting Phase III comparator…
Read More »
New Delhi, Jyoti Singh (India Science Wire): Multisystem inflammatory syndrome in children (MIS-C), affects a few children who have been…
Read More »
New Delhi: Indian Institute of Chemical Technology (IICT), Hyderabad, a constituent laboratory of Council of Scientific and Industrial Research (CSIR),…
Read More »